Neil F. McFarlane, President and CEO: Zevra Therapeutics ZVRA Sell · Filed 02/10

Trade details

Type: Insider sale
Amount: $125,190
Shares · price: 14,625 sh · $8.56 a share
Held after: 387,225 sh
Stock: Zevra Therapeutics ZVRA
Person: Neil F. McFarlanePresident and CEO
Trade date: 26/02/09
Filed: 26/02/10
Days to filing: 1 days

Sold 3.6% of holdings

Share of holding sold: 3.6%

Zevra Therapeutics trades, last 26 weeks

What else happened in Zevra Therapeutics around then

Filed or reported within 30 days of the trade day · 01/10~03/11

Neil F. McFarlane's recent trades

Neil F. McFarlanePresident and CEO
Sell10b5-1 planZevra Therapeutics
Sell10b5-1 plan
Zevra Therapeutics
ZVRA
$853.6K
91,000 sh
$853.6K
Filed 02/02
Traded 02/02
Neil F. McFarlanePresident and CEO
Planned sale10b5-1 planZevra Therapeutics
Planned sale10b5-1 plan
Zevra Therapeutics
ZVRA
$950.6K
105,625 sh
$950.6K
Filed 02/02
Traded 02/02
Neil F. McFarlanePresident and CEO
Sell10b5-1 planZevra Therapeutics
Sell10b5-1 plan
Zevra Therapeutics
ZVRA
$211K
19,500 sh
$211K
Filed 25/10/10
Traded 25/10/10
Neil F. McFarlanePresident and CEO
Planned sale10b5-1 planZevra Therapeutics
Planned sale10b5-1 plan
Zevra Therapeutics
ZVRA
$211K
19,500 sh
$211K
Filed 25/10/10
Traded 25/10/10
Neil F. McFarlanePresident and CEO
Sell10b5-1 planZevra Therapeutics
Sell10b5-1 plan
Zevra Therapeutics
ZVRA
$481.6K
61,273 sh
$481.6K
Filed 25/02/14
Traded 25/02/13

Neil F. McFarlane, CEO — sold $125.2K of Zevra Therapeutics ZVRA · 3.6% of holdings · 10b5-1 plan | Whalegun